Dapsone (also called Diphenylsulfone, DDS, or Avlosulfon) is an anti-infective sulfone drug, commonly used to treat a form of dermatitis (herpetiformis) and susceptible cases of leprosy (Hansen’s disease). In recent years Dapsone has also proved useful in treating lupus, rheumatoid arthritis and as a second-line treatment for ITP. The exact mechanism by which Dapsone assists in ITP is unclear, however, limited studies report successful increases in platelet counts of around 40-50% of patients taking the drug.
Dosage
Dapsone is usually prescribed at between 25mg to 100mg per day. It takes an average of 3-4 weeks to effect platelet count. Regular blood counts should be performed to monitor potential hemolysis (red blood cell destruction and anemia). Liver function tests are also recommended.
Side Effects
Dapsone is generally well-tolerated despite its effects on red blood cells. Most side effects are dose-related and reversible.
Common: Hemolytic anemia (reduction in red blood cells), lowered hemoglobin (~1-2g), agranulocytosis (reduction in white blood cells), pale skin, fatigue.
Dapsone is not recommended for people with a glucose-6-phosphate dehydrogenase (G6PD) deficiency, severe anemia, methemoglobin reductase deficiency, or an allergy or sensitivity to sulfonamides. It is also unsuitable for those with liver or kidney problems, as well as pregnant women and nursing mothers.
IMPORTANT!
The information on this web site is for educational purposes only.
For advice on your unique medical condition, please consult
your healthcare professional.
Copyright 1997 - - Platelet Disorder Support Association
P.O. Box 61533, Potomac, MD 20859
Phone: 1- 87-PLATELET (877) 528-3538 or (301) 770-6636
Fax: (301) 770-6638 - e-mail: pdsa@pdsa.org